Endoscopic Retrograde Cholangiopancreatography

Methodist Health System

Status: Enrolling

Conditions: Gastro-Intestinal Disorder

Treatments: Other: Patients undergoing ERCPs at Methodist Dallas Medical Center

Study type: Observational

Funder types: Other

Identifiers

NCT07490132

046.GID.2024.D

Details and patient eligibility

About

The risk of post-endoscopic retrograde cholangiopancreatography(ERCP) pancreatitis(PEP) is influenced by patient and procedure-related factors. Strategies to decrease PEP(Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis) are of great importance.

Full description

The primary objective of this study is to provide a mechanism to store the following information about patients undergoing ERCPs at Methodist Dallas Medical Center. This registry will be permissive of quality improvement and research studies.

Enrollment: 100 estimated patients

Sex: All

Ages: 15+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

Patients >15 years Included in MDI's Registry Underwent ERCP between January 1, 2000 through December 31, 2025

Exclusion criteria

Patients <15 years Patients in which cannulation was via a surgical anastomosis Patients in which cannulation was not attempted due to gastric outlet obstruction, the main papilla not found, or the minor papilla was not found will be excluded.

Trial design

100 participants in 1 patient group

Underwent ERCP

Description:

Underwent ERCP between January 1, 2000 through December 31, 2025

Treatment:

Other: Patients undergoing ERCPs at Methodist Dallas Medical Center